Monday, the center “Vector” begins clinical trials of a vaccine against coronavirus, news agencies reported.
Will be vaccinated the first volunteers, RIA “Novosti”.
Testing will begin with a group of 10 people aged 18 to 30 years. Later, the tests will join the volunteers before the age of 60 years. It is planned to test the vaccine on 300 volunteers, including 60 employees of the center. The first phase of clinical trials will be completed in September.
We will remind, on July 24, Rospotrebnadzor said that “Vector” has allowed clinical trials of a vaccine against coronavirus.
Note that the Russian defense Ministry and the Research center of Gamaliel had already successfully completed phase clinical trials.
